Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution is a Ophthalmic Solution in the Human Prescription Drug category. It is labeled and distributed by Apotex Corp.. The primary component is Brimonidine Tartrate; Timolol Maleate.
| Product ID | 60505-0589_1795ad93-bc81-d5b0-f4c8-63782410ff50 |
| NDC | 60505-0589 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution |
| Generic Name | Brimonidine Tartrate And Timolol Maleate |
| Dosage Form | Solution |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2022-10-19 |
| Marketing Category | ANDA / |
| Application Number | ANDA091442 |
| Labeler Name | Apotex Corp. |
| Substance Name | BRIMONIDINE TARTRATE; TIMOLOL MALEATE |
| Active Ingredient Strength | 2 mg/mL; mg/mL |
| Pharm Classes | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Blocker [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |